Shibata T - Search Results

1

Current state of therapeutic development for rare cancers in Japan, and proposals for improvement.

Kawai A, Goto T, Shibata T, Tani K, Mizutani S, Nishikawa A, Shibata T, Matsumoto S, Nagata K, Narukawa M, Matsui S, Ando M, Toguchida J, Monden M, Heike T, Kimura S, Ueda R. Kawai A, et al. Among authors: shibata t. Cancer Sci. 2018 May;109(5):1731-1737. doi: 10.1111/cas.13568. Cancer Sci. 2018. PMID: 29878624 Free PMC article.

2

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy.

Yonemori K, Ando M, Shibata T, Katsumata N, Matsumoto K, Yamanaka Y, Kouno T, Shimizu C, Fujiwara Y. Yonemori K, et al. Among authors: shibata t. J Cancer Res Clin Oncol. 2006 Oct;132(10):635-42. doi: 10.1007/s00432-006-0110-z. Epub 2006 Jun 22. J Cancer Res Clin Oncol. 2006. PMID: 16791594

3

Age disparity between a cancer population and participants in clinical trials submitted as a new drug application of anticancer drugs in Japan.

Hori A, Shibata T, Kami M, Kusumi E, Narimatsu H, Kishi Y, Murashige N, Mori K. Hori A, et al. Among authors: shibata t. Cancer. 2007 Jun 15;109(12):2541-6. doi: 10.1002/cncr.22721. Cancer. 2007. PMID: 17477381 Free article.

4

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome.

Shien T, Shimizu C, Seki K, Shibata T, Hojo T, Ando M, Kohno T, Katsumata N, Akashi-Tanaka S, Kinoshita T, Fujiwara Y. Shien T, et al. Among authors: shibata t. Breast Cancer Res Treat. 2009 Jan;113(2):307-13. doi: 10.1007/s10549-008-9935-2. Epub 2008 Feb 20. Breast Cancer Res Treat. 2009. PMID: 18286370

5

Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma.

Hirakawa A, Nishikawa T, Yonemori K, Shibata T, Nakamura K, Ando M, Ueda T, Ozaki T, Tamura K, Kawai A, Fujiwara Y. Hirakawa A, et al. Among authors: shibata t. Ther Innov Regul Sci. 2018 May;52(3):334-338. doi: 10.1177/2168479017728989. Epub 2017 Sep 8. Ther Innov Regul Sci. 2018. PMID: 29714533 Clinical Trial.

6

MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial.

Okuma HS, Yonemori K, Narita SN, Sukigara T, Hirakawa A, Shimizu T, Shibata T, Kawai A, Yamamoto N, Nakamura K, Nishida T, Fujiwara Y. Okuma HS, et al. Among authors: shibata t. Clin Pharmacol Ther. 2020 Sep;108(3):596-605. doi: 10.1002/cpt.1817. Epub 2020 Apr 7. Clin Pharmacol Ther. 2020. PMID: 32112563 Free PMC article.

7

Rare cancers in Japan: definition, clinical features and future perspectives.

Kawai A, Higashi T, Shibata T, Yoshida A, Katoh Y, Fujiwara Y, Nishida T. Kawai A, et al. Among authors: shibata t. Jpn J Clin Oncol. 2020 Sep 5;50(9):970-975. doi: 10.1093/jjco/hyaa121. Jpn J Clin Oncol. 2020. PMID: 32719865 Review.

8

Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510).

Nishikawa T, Kakunaga S, Tamura K, Ando M, Ozaki T, Kawai A, Ueda T, Kawasaki M, Tomatsuri S, Okamura N, Kamikura M, Hamada A, Yoshida A, Hirakawa A, Shibata T, Nakamura K, Yonemori K. Nishikawa T, et al. Among authors: shibata t. Cancer. 2024 Nov 15;130(22):3836-3844. doi: 10.1002/cncr.35483. Epub 2024 Jul 30. Cancer. 2024. PMID: 39077795 Clinical Trial.

9

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.

Yonemori K, Hasegawa T, Shimizu C, Shibata T, Matsumoto K, Kouno T, Ando M, Katsumata N, Fujiwara Y. Yonemori K, et al. Among authors: shibata t. Pathol Res Pract. 2006;202(10):705-12. doi: 10.1016/j.prp.2006.05.006. Epub 2006 Aug 2. Pathol Res Pract. 2006. PMID: 16889904

10

Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705).

Ogura M, Itoh K, Ishizawa K, Kobayashi Y, Tobinai K, Kinoshita T, Hirano M, Ueda R, Shibata T, Nakamura S, Tsukasaki K, Hotta T, Shimoyama M, Morishima Y; Lymphoma Study Group (LSG) of Japan Clinical Oncology Group (JCOG). Ogura M, et al. Among authors: shibata t. Leuk Lymphoma. 2013 Jan;54(1):46-52. doi: 10.3109/10428194.2012.705000. Epub 2012 Aug 21. Leuk Lymphoma. 2013. PMID: 22712838 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,226 results

Search Page

Filters